Inari Medical (NARI) Stock Forecast & Price Target

$45.52

+3.84 (+9.21%)

(As of 09/6/2024 ET)

Inari Medical - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 10 Analyst Ratings

Based on 10 Wall Street analysts who have issued ratings for Inari Medical in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 10 analysts, 5 have given a hold rating, and 5 have given a buy rating for NARI.

Consensus Price Target

$59.50
30.71% Upside

High Forecast	$71.00
Average Forecast	$59.50
Low Forecast	$47.00

According to the 10 analysts' twelve-month price targets for Inari Medical, the average price target is $59.50. The highest price target for NARI is $71.00, while the lowest price target for NARI is $47.00. The average price target represents a forecasted upside of 30.71% from the current price of $45.52.

Type	Current Forecast 9/8/23 to 9/7/24	1 Month Ago 8/9/23 to 8/8/24	3 Months Ago 6/10/23 to 6/9/24	1 Year Ago 9/8/22 to 9/8/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	4 Buy rating(s)	5 Buy rating(s)	6 Buy rating(s)
Hold	5 Hold rating(s)	3 Hold rating(s)	2 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$59.50	$60.17	$65.71	$85.22
Forecasted Upside	30.71% Upside	29.81% Upside	37.24% Upside	32.01% Upside

Get Inari Medical Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NARI and its competitors with MarketBeat's FREE daily newsletter.

Ad Golden Crest

Biden’s Capital Gains Tax to Devastate Savings!

Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.

>> Get Your FREE Wealth Protection Guide <<

NARI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NARI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Inari Medical Stock vs. The Competition

Type	Inari Medical	Medical Companies	S&P 500
Consensus Rating Score	2.50	2.77	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	30.71% Upside	1,206.55% Upside	11.36% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/3/2024	Leerink Partnrs 0 of 5 stars	M. Kratky Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
9/3/2024	Leerink Partners 1 of 5 stars		Initiated Coverage	Market Perform	$47.00	+8.72%
8/26/2024	Piper Sandler 2 of 5 stars		Reiterated Rating	Neutral ➝ Neutral	$50.00 ➝ $50.00	+16.52%
8/9/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$68.00	+39.57%
7/31/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$84.00 ➝ $65.00	+39.16%
7/31/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Hold ➝ Hold	$60.00 ➝ $55.00	+17.62%
Get the Latest News and Ratings for NARI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter.
7/31/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$55.00 ➝ $71.00	+54.68%
7/31/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$65.00 ➝ $63.00	+20.90%
7/31/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Matson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold
7/25/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Kaczor Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform
8/3/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$83.00	+28.15%
10/17/2022	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$100.00 ➝ $97.00	+34.00%
10/12/2022	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$88.00	+20.83%
9/29/2022	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$85.00	+16.33%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 08:44 PM ET.

NARI Forecast - Frequently Asked Questions

What is Inari Medical's forecast for 2024?: According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Inari Medical is $59.50, with a high forecast of $71.00 and a low forecast of $47.00.
Should I buy or sell Inari Medical stock right now?: 10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inari Medical in the last twelve months. There are currently 5 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" NARI shares.
Does Inari Medical's stock price have much upside?: According to analysts, Inari Medical's stock has a predicted upside of 29.34% based on their 12-month stock forecasts.
Has Inari Medical been upgraded or downgraded by Wall Street analysts recently?: Over the previous 90 days, Inari Medical's stock had 1 upgrade and 1 downgrade by analysts.
What analysts cover Inari Medical?: Inari Medical has been rated by research analysts at Canaccord Genuity Group, Deutsche Bank Aktiengesellschaft, Leerink Partners, Leerink Partnrs, Needham & Company LLC, Piper Sandler, Robert W. Baird, Truist Financial, Wells Fargo & Company, and William Blair in the past 90 days.
Do Wall Street analysts like Inari Medical more than its competitors?: Analysts like Inari Medical less than other "medical" companies. The consensus rating score for Inari Medical is 2.50 while the average consensus rating score for "medical" companies is 2.77. Learn more on how NARI compares to other companies.